Drugs / MYL-1601D
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03760068 Comparator | Nov 2018 → Dec 2019 | type 1 diabetes mellitus | Mylan Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MYL-1601D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03760068 ↗ |